Search

Embecta Corp

Chiusa

SettoreSettore sanitario

4.42 26.65

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

4.41

Massimo

4.65

Metriche Chiave

By Trading Economics

Entrata

-48M

-4.1M

Vendite

-39M

222M

P/E

Media del settore

1.928

68.51

EPS

0.27

Rendimento da dividendi

16.48

Margine di Profitto

-1.849

Dipendenti

1,850

EBITDA

-51M

45M

Raccomandazioni

By TipRanks

Raccomandazioni

Vendi

Previsioni per 12 mesi

-32.13% downside

Dividendi

By Acuity

Rendimento da dividendi

Media del settore

16.48%

2.29%

Prossima data del Dividendo

15 set 2026

Prossima data del' Ex Dividendo

27 ago 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-327M

221M

Apertura precedente

-22.23

Chiusura precedente

4.42

Notizie sul Sentiment di mercato

By Acuity

43%

57%

303 / 340 Classifica in Healthcare

Embecta Corp Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

7 ago 2026, 23:31 UTC

Embecta Corp is higher in after-market trading, reflecting positive momentum amid broader market strength and significant gains in major tech stocks.

6 ago 2026, 23:42 UTC

Embecta Corp shares are higher in after-market hours, recovering from earlier lows. No specific news was identified to explain this movement.

5 ago 2026, 22:36 UTC

News

Embecta Corp faces a securities fraud class action lawsuit over misleading fiscal statements, contributing to a modest decline in after-market trading.

4 ago 2026, 19:26 UTC

Embecta Corp shares are higher during Tuesday's session, reaching a session high. No specific company news was identified to explain the upward movement.

3 ago 2026, 20:03 UTC

Embecta Corp shares are higher today, benefiting from positive investor sentiment in the health care supplies sector amid a rising broader market.

31 lug 2026, 21:02 UTC

Embecta Corp shares are lower in after-market hours, continuing a recent decline amid broader market concerns over inflation and rising interest rates.

30 lug 2026, 21:02 UTC

Embecta Corp shares are higher in after-market trading, amid positive market sentiment focused on corporate earnings despite geopolitical tensions and inflation concerns.

29 lug 2026, 19:04 UTC

Embecta Corp gains amid a strong Health Care Supplies sub-sector, despite pulling back from earlier session highs. Overall, shares are higher since Tuesday's close.

28 lug 2026, 22:01 UTC

Embecta Corp shares are higher in after-market hours, continuing a positive trend since Tuesday's close. No specific news was identified to explain the movement.

27 lug 2026, 18:03 UTC

Embecta Corp shares are trading higher, continuing a rise since Friday amid broader market movements and easing inflation concerns, despite earlier pulling back from session highs.

24 lug 2026, 21:31 UTC

News

Embecta Corp is facing a securities class action lawsuit for allegedly misleading investors about its fiscal results, contributing to lower after-market hours trading.

22 lug 2026, 18:02 UTC

News

Embecta Corp shares are lower today amid a securities fraud class action lawsuit filed by Levi & Korsinsky, LLP, targeting misrepresentation of financial health.

21 lug 2026, 23:01 UTC

Embecta Corp shares are higher in after-market trading, reflecting a strong position above its 20-day moving average and near the upper end of its one-month range.

20 lug 2026, 19:52 UTC

Embecta Corp shares are rising sharply, reaching the upper end of their one-month range amid positive broader market sentiment, particularly from Asian markets.

Confronto tra pari

Modifica del prezzo

Embecta Corp Previsione

Obiettivo di Prezzo

By TipRanks

-32.13% in calo

Previsioni per 12 mesi

Media 3 USD  -32.13%

Alto 3 USD

Basso 3 USD

Basato su 2 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Embecta Corp - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Vendi

2 ratings

0

Acquista

1

Mantieni

1

Vendi

Sentiment

By Acuity

303 / 340 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sopra la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Embecta Corp

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
help-icon Live chat